Particle-based, Pfs230 and Pfs25 immunization is effective, but not improved by duplexing at fixed total antigen dose
Published 2020 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Particle-based, Pfs230 and Pfs25 immunization is effective, but not improved by duplexing at fixed total antigen dose
Authors
Keywords
-
Journal
MALARIA JOURNAL
Volume 19, Issue 1, Pages -
Publisher
Springer Science and Business Media LLC
Online
2020-08-28
DOI
10.1186/s12936-020-03368-5
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Antibody response of a particle-inducing, liposome vaccine adjuvant admixed with a Pfs230 fragment
- (2020) Wei-Chiao Huang et al. npj Vaccines
- Identification of domains within Pfs230 that elicit transmission blocking antibody responses
- (2019) Mayumi Tachibana et al. VACCINE
- Pfs230 and Pfs48/45 Fusion Proteins Elicit Strong Transmission-Blocking Antibody Responses Against Plasmodium falciparum
- (2019) Susheel K. Singh et al. Frontiers in Immunology
- A Viral-Vectored Multi-Stage Malaria Vaccine Regimen With Protective and Transmission-Blocking Efficacies
- (2019) Yenni Yusuf et al. Frontiers in Immunology
- An Engineered Biomimetic MPER Peptide Vaccine Induces Weakly HIV Neutralizing Antibodies in Mice
- (2019) Shuai Shao et al. ANNALS OF BIOMEDICAL ENGINEERING
- Disulfide bond mapping of Pfs25, a recombinant malaria transmission blocking vaccine candidate
- (2018) Shwu-Maan Lee et al. ANALYTICAL BIOCHEMISTRY
- Assessment of Antibodies Induced by Multivalent Transmission-Blocking Malaria Vaccines
- (2018) Vinay Menon et al. Frontiers in Immunology
- Safety and immunogenicity of a plant-produced Pfs25 virus-like particle as a transmission blocking vaccine against malaria: A Phase 1 dose-escalation study in healthy adults
- (2018) Jessica A. Chichester et al. VACCINE
- A malaria vaccine adjuvant based on recombinant antigen binding to liposomes
- (2018) Wei-Chiao Huang et al. Nature Nanotechnology
- Assessment of Pfs25 expressed from multiple soluble expression platforms for use as transmission-blocking vaccine candidates
- (2016) Shwu-Maan Lee et al. MALARIA JOURNAL
- Transmission-blocking activity is determined by transmission-reducing activity and number of control oocysts in Plasmodium falciparum standard membrane-feeding assay
- (2016) Kazutoyo Miura et al. VACCINE
- Plug-and-Display: decoration of Virus-Like Particles via isopeptide bonds for modular immunization
- (2016) Karl D. Brune et al. Scientific Reports
- Functionalization of cobalt porphyrin–phospholipid bilayers with his-tagged ligands and antigens
- (2015) Shuai Shao et al. Nature Chemistry
- Potent Malaria Transmission-Blocking Antibody Responses Elicited by Plasmodium falciparum Pfs25 Expressed in Escherichia coli after Successful Protein Refolding
- (2014) Rajesh Kumar et al. INFECTION AND IMMUNITY
- Algae-Produced Pfs25 Elicits Antibodies That Inhibit Malaria Transmission
- (2012) James A. Gregory et al. PLoS One
- Developments in virus-like particle-based vaccines for infectious diseases and cancer
- (2011) Luigi Buonaguro et al. Expert Review of Vaccines
- The IC50 of anti-Pfs25 antibody in membrane-feeding assay varies among species
- (2010) Lediya Cheru et al. VACCINE
- Functional immunogenicity of baculovirus expressing Pfs25, a human malaria transmission-blocking vaccine candidate antigen
- (2010) Godfree Mlambo et al. VACCINE
- Phase 1 Trial of Malaria Transmission Blocking Vaccine Candidates Pfs25 and Pvs25 Formulated with Montanide ISA 51
- (2008) Yimin Wu et al. PLoS One
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started